Please enable JavaScript.
Coggle requires JavaScript to display documents.
Gastritis (Diagnosis ((Endoscopy (Wehbi, 2019) (Thick, edematous wall…
Gastritis
Diagnosis
Endoscopy (Wehbi, 2019)
Thick, edematous wall (Wehbi, 2019)
Erosion/ulcer formation (Wehbi, 2017)
Red, inflamed folds (Wehbi, 2019)
Histology/Biopsy (Wehbi, 2019)
Radiography (Wehbi, 2019)
Thick gastric folds (Wehbi, 2019)
Gastric inflammatory nodules (Wehbi, 2019)
Enlarged gastric area (Wehbi, 2019)
Complications (Wehbi, 2019)
Infection (Wehbi, 2019)
H. pylori testing (Wehbi, 2019)
Bleeding (Wehbi, 2019)
Complete Blood Count (Wehbi, 2019)
Stool testing for blood (Wehbi, 2019)
Past medical history/physical examination (Wehbi, 2019)
Epidemiology
Risk Factors
Alcohol consumption (Wehbi, 2019)
NSAID/Aspirin use (Wehbi, 2019)
-
-
-
Food poisoning/allergy (Wehbi, 2019)
H. pylori infections are the most common cause (Wehbi, 2019)
Cause of over 2 million office visits each year (Wehbi, 2019)
Pathophysiology
Chronic immune gastritis (Huether & McCance, 2017)
Antibodies attack parietal cells (Huether & McCance, 2017)
Decreased HCl secretion (Huether & McCance, 2017)
Gastric atrophy (Huether & McCance, 2017)
mucosal barrier degradation (Huether & McCance, 2017)
Acute Gastritis (Huether & McCance, 2017)
Mucosal barrier damage (Huether & McCance, 2017)
Diminished mucus secretion (Huether & McCance, 2017)
Inhibited prostaglandin synthesis (Huether & McCance, 2017)
HCl hypersecretion (Huether & McCance, 2017)
Reduced gastric mucosal pH (Huether & McCance, 2017)
Gastric mucosal inflammation (Huether & McCance, 2017)
Irritant exposure (Huether & McCance, 2017)
H. pylori infection (Huether & McCance, 2017)
Aspirin/NSAID use (Huether & McCance, 2017)
Alcohol (Huether & McCance, 2017)
Chronic Nonimmune gastritis (Huether & McCance, 2017)
H. pylori bacterial infection (Wehbi, 2019)
Inflammatory response activation (Wehbi, 2019)
Epithelial cell inflammation and damage (Wehbi, 2019)
Parietal cell damage (Wehbi, 2019)
Hypersecretion of HCl acid (Wehbi, 2019)
Clinical Presentation
Clinical Manifestations
Epigastric tenderness = most common (Wehbi, 2019)
Vague abdominal pain (Huether & McCance, 2017)
Nausea/Vomiting (Huether & McCance, 2017)
Anorexia (Huether & McCance, 2017)
Gastric bleeding (Huether & McCance, 2017)
Typically asymptomatic until complications occur (Wehbi, 2019)
Complications
Ulcer formation (Huether & McCance, 2017)
Gastric adenocarcinoma (Hammer & McPhee, 2019)
Bleeding (Huether & McCance, 2017)
mucosa-associated lymphoid tissue lymphoma (MALToma) (Hammer & McPhee, 2019)
Treatment
Supportive Care (Wehbi, 2019)
Electrolyte replacement (Wehbi, 2019)
Antiemetics (Wehbi, 2019)
IV fluid administration (Wehbi, 2019)
Lifestyle changes (Wehbi, 2019)
Smaller, more frequent meals (Huether & McCance, 2017)
Alcohol cessation (Huether & McCance, 2017)
Bland diet (Huether & McCance, 2017)
Aspirin/NSAID avoidance (Huether & McCance, 2017)
H. pylori infection (Wehbi, 2019)
Amoxicillin (Wehbi, 2019)
Retesting 4 wks following antibiotic completion (Wehbi, 2019)
Levofloxacin (Wehbi, 2019)
Proton Pump inhibitor (Wehbi, 2019)
-